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Introduction
Bee venom, as a therapeutic modality in use since at least the
second century BC in Eastern Asia, has been extensively
researched and practiced in Korea, focusing on clinical appli-
cations as a meridian therapy (1). Herbal acupuncture is a new
method of acupuncture where a distilled herbal decoction is
extracted, and purified to be administered on acupoints for
stimulation (2). Bee venom acupuncture (BVA) is a kind of
herbal acupuncture taking advantage of diluted bee venom
instead of distilled herbal decoction (2). The bee venom once
extracted and processed is utilized on the relevant sites accord-
ing to specific diseases or acupoints. BVA simultaneously
exerts pharmacological actions from the bioactive compounds
isolated from bee venom and mechanical actions from the
acupuncture stimulation. BVA has been considered as a prom-
ising therapeutic method for various diseases, especially in
Korean medicine. BVA has long been used in a variety of
conditions and good evidence for its effectiveness exists in
pain syndrome, herniation nucleus pulpous, cervical disc
protrusion and progressive muscle atrophy (3–6).
Rheumatoid arthritis (RA) is an autoimmune disorder of
unknown etiology that is characterized by progressive joint
destruction, deformity, disability and premature death in most
patients. Osteoarthritis (OA) is characterized by degeneration
of articular cartilage with proliferation and remodeling of sub-
chondral bone. In complementary and alternative medicine
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used to treat a number of human inflammatory diseases includ-
ing rheumatoid arthritis and osteoarthritis (7,8). Moreover,
there are a sufficient number of studies using CAM therapies,
including herbal therapy, glucosamine, chondroitin sulfate and
S-adenosylmethionine, in these conditions despite claims often
heard about the lack of evidence for CAM (9). It is notable that
BVA demonstrated anti-inflammatory and analgesic actions in
animal studies (10–19) as well as in clinical trials (20–23).
However, the effectiveness of BVA for this indication is still
not well known and no review of this subject exists.
The purpose of the present study was, therefore, to evaluate the
data from experimental and clinical studies and to explore further
ways to better comprehend the effectiveness of BVA on arthritis.
Methods
Data Sources
Computerized literature searches for experimental studies and
clinical trials of BVA for arthritis were performed on the data-
bases from PUBMED, EMBASE and the Cochrane Library. In
addition, two leading Korean journals (The Journal of Korean
Society for Acupuncture and Moxibustion and  The Journal
of Korean Oriental Medicine) were searched for relevant
studies. The search terms ‘bee venom’, ‘bee venom therapy’,
‘acupuncture’and ‘anti-inflammation’, ‘rheumatic arthritis’or
‘osteoarthritis’were used. Further hand-searches were performed
in the reference lists of all located articles.
Categorization of Studies
For experimental analysis, we focused on the animal research that
have evaluated anti-inflammatory and anti-nociceptive effects.
For clinical studies, we included all trials with rheumatoid
arthritic and osteoarthritic patients. We included the papers in our
review only when they applied bee venom treatment to acupoints.
The search found 67 studies, of which 15 met our criteria.
Quality Assessment
The methodological quality of each randomized controlled
trial (RCT) was rated according to the Jadad scale (24). Points
were awarded as follows: the study was described as random-
ized, 1 point; the randomization scheme was described and
appropriate, 1 point; the study was described as double blind,
1 point; the method of double blinding was appropriate, 1 point;
there was a description of withdrawals and dropouts, 1 point.
The maximum point-score available was 5.
Results
Anti-inflammatory and Anti-nociceptive Effects of BVA
in Animals
The anti-inflammation and analgesic effects of BVA have been
proven in various kinds of animal arthritic models, such as
adjuvant, carrageenan or lipopolysaccharide (LPS)-induced
arthritis.
Kwon et al. (10) and Seo et al. (12) conducted a compara-
tive study of acupoint versus non-acupoint stimulation on an
adjuvant induced RA animal model with BVA. Direct injection
of bee venom into acupoint ST36 produced a potent anti-noci-
ceptive effect, suggesting that this alternative form of acupoint
stimulation using bee venom can be applied for relieving pain.
Kim et al. (14) and Choi et al. (13) conducted an experiment
to show effectiveness of BVA at acupoint ST36 by inducing
arthritis in rats by a mixture of type II collagen. It compared
levels of proteolytic enzyme activities and free-radical-
induced protein damage in synovial fluid from this animal
model. BVA at acupoint BL23 significantly reduced prote-
olytic enzyme activities and level of reactive oxygen species
(ROS)-induced oxidative damage to synovial fluid proteins in
this model (14).
Doh et al. (17) observed anti-inflammatory effects on knee
arthritis induced by carrageenan in rats. Numbers of white
blood cells and red blood cells increased, and values of hemo-
globin hematocrit also showed significant therapeutic effects.
Lee et al. (18) administered bee venom at acupoint ST36 prior
to carrageenan, and evaluated acute edema and heat on the paw
and analyzed the Fos expression of the spinal cord quantita-
tively. Pretreatment with BVA prior to carrageenan adminis-
tration inhibited both carrageenan-induced edema and heat on
the paw, showing clear correlation between change rates of
edema on the foot and the expression of Fos positive neutron
on the spinal cord.
The effects of BVA at acupoint GB34 on LPS-induced arthri-
tis were conducted to examine the therapeutic effects of BVA in
mice (15,19). Bee venom decreased numbers of white blood
cells, infiltration of leukocytes and fibroblasts into synovial
joints, CD56, IL-1  , IL-2R, CD54 and CD106 in synovial
membrane when compared with controls.
Kim  et al. (16) and Yim et al. (11) administered adult
Sprague–Dawley rats with bee venom directly into acupoint
ST36 or into an arbitrary non-acupoint located on the back.
Pretreatment with bee venom into the ST36 acupoint signifi-
cantly decreased paw-licking time in the late phase of the for-
malin test and also markedly inhibited spinal cord Fos
expression induced by formalin injection.
Several studies suggest that the effects of BVA depend on
the locations injected; acupuncture points exert much stronger
effects than non-acupoints (10–12,16). The effects of bee
venom might be intensified by acupuncture stimulations,
which may help in reaching therapeutic goals.
Favorable Effects of BVA on RA and OA Patients in
Clinical Trials
One RCT and two uncontrolled clinical trials were found for
RA (Table 1). Kwon (20) performed BVA on 10 patients diag-
nosed with RA. The results showed 90% validity with remark-
able improvement in two cases, good improvement in five
cases, and effective improvement in two cases. In Lee et al.’s
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study (21), patients with RA who met ACR (American College
of Rheumatology) 1987 revised criteria for diagnosis of RA
were treated with BVA therapy twice a week for 3 months.
Tender joint counts, swollen joint counts and duration of
morning stiffness in patients after BVA therapy was signifi-
cantly lower than those before BVA therapy. Lee et al. (22)
also performed the RCT for evaluating effects of BVA in RA
patients. RA patients were recruited and randomly divided into
a BVA group and a control group by random selection. Each
group was treated with BVA or normal saline injection on acu-
points twice a week for 8 weeks. Tender joint count, swollen
joint count, morning stiffness, pain, health assessment ques-
tionnaire, ESR (erythrocyte sedimentation rate) and CRP 
(C-reactive protein) were estimated and analyzed at baseline,
at 1 month and 2 months after BVA therapy. Compared to the
control group, the BVA group showed a significant decrease in
tender joint count, swollen joint count, morning stiffness and
health assessment questionnaire after 2 months. Pain, ESR and
CRP also showed a significant decrease in the BVA group after
1 and 2 months.
One RCT and one uncontrolled trial were searched for OA
(Table 2). Wang et al. (23) reported on treatment by BVA of
70 knee arthritis patients. The results were: excellent, 11 cases
(15.7%); good, 31 cases (44.3%); and improved, 16 cases
(22.9%). Kwon et al. (25) conducted an experiment to investi-
gate whether direct administration of bee venom into an acu-
point is a clinically effective and safe method for relieving pain
of patients with knee OA as compared to traditional needle
acupuncture. Four weeks of BVA treatment were followed by
pain relief scores and computerized infrared thermography
(IRT) for evaluation of efficacy of BVA. The group of subjects
receiving BVA showed substantial relief of pain as compared
to the group receiving traditional needle acupuncture, and the
IRT score was significantly improved to parallel the level of
pain relief. They demonstrated that a majority (82.5%) of sub-
jects receiving BVA (33 out of 40 subjects) reported substan-
tial pain relief as compared with traditional acupuncture
therapy (55%). The therapeutic efficacy was favorable irre-
spective of disease duration (acute, subacute or chronic stage),
arthritic type (unilateral or bilateral knee OA) and radiological
severity.
Discussion
Collective evidence from in vivo experiments shows that BVA
has a potent analgesic and anti-inflammatory effect. Two clin-
ical studies on degenerative arthritis and three clinical studies
on RA suggest that BVA may become a promising treatment
for both RA and OA. The number of controlled studies of BVA
in arthritis is quite small, and their quality is limited. However,
it would be worth considering BVA as an applicable treatment
for arthritis in CAM.
Many animal investigations cited in this review have shown
that BVA is capable of producing anti-nociception and anti-
inflammatory actions in several animal models (10–19).
Several studies suggested that the effects of bee venom were
intensified by acupuncture stimulations, which may help in
reaching therapeutic goals. The anti-nociceptive property of
Table 1. The effects of bee venom acupuncture (BVA) on rheumatoid arthritis
Author (year) Study design Study quality* Groups and interventions Outcome measure and results
Lee SH, Hong SJ  Randomized, 1   0   1   1 • Tender joint count: BVA   control 
et al. (2003) controlled, two   1   4( P   0.05)
groups • Swollen joint count: BVA   control 
(P   0.05)
• Morning stiffness: BVA   control
(P   0.05)
• Laboratory findings:
• ESR: BVA   control (P   0.05);
• CRP: BVA   control (P   0.05)
Lee SH, Lee HJ Uncontrolled NA • Tender joint counts: before   after
et al. (2003) (P   0.01)
• Swollen joint counts: before   after 
(P   0.01)
• Analgesic effect with visual analogue
scale: before   after (P  0.001)
• Morning stiffness: before   after 
(P   0.01)
Kwon KR  Uncontrolled NA • 90% clinical improvements in 
et al. (1998) symptoms. Remarkable improvement,
two cases; good improvement, five 
cases; effective, two cases
*Jadad score (randomization 1 point   appropriate randomization method 1 point   blinding 1 point   appropriate blinding method 1 point   describing
withdrawals and dropouts 1 point   maximum 5 points).
ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.
• Rheumatic arthritis patients (n   80):
BVA group (n   40) and control group
(n   40).
• Treatment: twice a week for 
2 months, BVA at proximal and distal 
phalangeal joints: SI5, LI5, PC7, TE4, LI11,
TE10, HT3, SI8 ST36, GB34, SP9, EX-LE2,
EX-LE4, GB40, BL62, SP5 and KI6,
according to patients’symptomatic areas
• Rheumatic arthritis patients .
(n   22)
• Treatments: twice a week for 
3 months, BVA at proximal and distal 
phalangeal joints SI5, LI5, PC7, TE4, LI11,
TE10, HT3, SI8, ST36, GB34, SP9,
EX-LE2, EX-LE4, GB40, BL62, SP5 and 
KI6, according to patients’symptomatic 
areas
• Rheumatoid arthritis patients (n   10)BVA may be explained by the process of counter irritation;
that is, when noxious stimuli are applied to body regions, these
stimuli increase the pain thresholds and reduce pain rating
scores through the body. For centuries, pain has been relieved
by counter-irritation methods such as moxibustion (a method
of burning herbs to stimulate acupuncture points) on arthritic
limbs (25).
The two uncontrolled investigations (20,21) and one RCT
study (22) from the above search results showed that bee
venom therapy was very effective in the treatment of RA. The
treatment goal for RA can be summarized as follows: first,
pain and inflammation should be prevented, since it can lead
to pain in the joints, disformity of the joints, or loss of func-
tions; second, chronic inflammation is inhibited so that loss of
function in the joints is prevented or minimized to help
patients back to normal life. The RCT study of Lee et al. (22)
observed that BVA treatment improved the number of painful
joints, swollen joints, morning stiffness and hematological
indices. Utilizing the Korean health-related questionnaire, it
also showed that BVA treatment could contribute to improve-
ment of patients’ quality of life.
One RCT investigations (25) and one uncontrolled trial
study (23) demonstrated that herbal acupuncture using bee
venom for knee arthritis was effective. Previous studies have
established the effectiveness of acupuncture treatment both in
relieving pain and recovering dysfunction of knees in elderly
patients with OA in comparison to non-acupuncture treated
control groups (26). Kwon et al. (25) compared therapeutic
effects of acupuncture by hand manipulation with herbal
acupuncture using bee venom. BVA is more effective than
acupuncture. Computerized IRT objectively displayed changes
in skin temperature in the painful region. Computerized IRT is
a method of examination whereby infrared rays naturally emit-
ted from the body are detected, displaying minute changes in
body temperature on painful or other diseased parts on the
computer monitor. It is a widely employed method of exami-
nation, now used for evaluation of pain and prognosis. Kwon
et al. (25) showed that the temperature on the knee region sig-
nificantly decreased after treatment with bee venom. However,
significant change was examined in all groups with severe,
moderate or mild degrees of degenerative arthritis.
RA is a typical autoimmune disease, of which exact
causative factor have not yet been verified various aspects. The
pathogenesis and pathophysiology of RA are being investigated.
Until now, there are no methods recommended from perfect
prevention or perpetual extermination after onset of RA.
Existing methods of treatment for RA can be categorized as
medication, surgery, rehabilitation and physical therapy.
Medication therapy used in most cases utilizes various
kinds of medicine such as NSAIDs, adrenal cortical hormone,
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Table 2. The effects of bee venom acupuncture (BVA) on osteoarthritis
Author (year) Study design Study quality* Groups and interventions Outcome measure and results
Kwon YB  Randomized, 1   0   0   0
et al. (2001) controlled,   0   1
two groups
Wang OH  Uncontrolled NA
et al. (2001)
*Jadad score (randomization 1 point   appropriate randomization method 1 point   blinding 1 point   appropriate blinding method 1 point   describing
withdrawals and dropouts 1 point   maximum 5 points).
Acu, acupuncture; NA, not applicable; NS, not significant.
● Knee osteoarthritic patients 
(n   60): BVA (n   40) and 
acupuncture (n   20)
Treatments:
● BVA: twice a week for 4 weeks 
at Ex-LE2, and Ex-LE5 and LR8.
● Acu: once a day needles were selected
within five points (or 10 bilaterally) 
among acupoints SP10, ST34, ST36,
GB34, LR3, Ex-LE2 and Ex-LE5  
considering individual symptoms 
for 20 min.
● Deqi sensation was induced.
● Knee osteoarthritic patients (n   70)
● Treatments: BVA once or twice 
a week at EX-LE2, EX-LE4, LR3 
and ST34
● Subjective pain relief score
● Excellent improvement: BVA 
(37.5%),Acu (5%)
● Good improvement: BVA (45%),
Acu (50%)
● Fair: BVA (17.5%),Acu (40%)
● Poor: BVA (0%),Acu (5%)
● Comparison of the effects between 
BVA and Acu: BVA   Acu 
(P   0.01 by Mann-Whitney U-test).
● Lysholm and Karsson’s knee joint 
evaluation scale:
● Limp: Pretreatment   Posttreatment
● Assitive device: NS
● Up stair: Pretreatment   Posttreatment
● Giving way: Pretreatment   Posttreatment
● Squat: Pretreatment   Posttreatment
● Sit down and up: Pretreatment   Posttreatment
● Crepitation: Pretreatment   Posttreatment
● Swelling: Pretreatment   Posttreatment
● Pain: Pretreatment   Posttreatmentconcentration of bee venom should be carefully considered.
Studies on the standardization of such measurements are also
required.
Most systematic reviews of therapeutic interventions include
only RCTs, which are generally considered as the gold
standard for evaluation. However, the medical literature is full
of non-randomized and uncontrolled studies. It is certainly
highly problematic to draw conclusions on causal effects from
non-randomized or uncontrolled studies. However, RCTs also
have flaws in other aspects. First, they often recruit only a
small and non-representative sample of patients who are then
treated and monitored under man-made conditions (31,32).
As a result, the degree to which the results can be generalized
and are externally valid is unclear. Second, RCTs in chronic
conditions have limited observation periods because of ethical
reasons, feasibility or resources (33,34). If the number or
quality of available randomized trials is not sufficient to draw
conclusions, non-randomized studies might be useful to give a
better overview of what is known so far and to inform future
research. It is obvious that the number of subjects and the
quality of the studies in this review have limitations. However,
BVA is considered to be highly promising in the treatment
of arthritis.
Conclusion
A sufficient number of animal studies have shown that BVA
has significant anti-inflammatory and analgesic effects. Due to
paucity and methodological flaws in the existing clinical stud-
ies, it is premature to draw any firm conclusions at this time.
However, the effectiveness of BVA for arthritis is likely to be
a promising area of future research. Rigorous trials with large
sample sizes and adequate design are required to define the
role of BVA for these indications.
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